|
| |
Colzani et al., Pisa, Italy, measured QT interval corrected for heart rate (QTc)
in 12 patients with hyperthyroidism (mean age 47.5 years) before and after
treatment and in 9 patients (mean age 49 ± 6 years) after total thyroidectomy
and I-131 ablation for thyroid carcinoma, when hypothyroid 6 weeks after
withdrawal of T4 (mean TSH 75mU/L) and during T4 administration (mean TSH 0.16mU/L).
Sixteen healthy volunteers (mean age 34 ± 2 years) formed the control group. In
addition plasma norepinephrine (NE) values were measured. NE levels were elevated
in the hypothyroid patients vs controls, p < 0.01, while being normal in the
hyperthyroid subjects. QTc was increased in the hypothyroid group vs the value
when patients were treated, p < 0.01, and controls, p < 0.01). In hyperthyroid
patients QTc was increased when untreated vs when patients were euthyroid, p < 0.02.
QTc and vs. controls p < 0.01. In treated hyperthyroids, QTc was not different from
controls. In untreated hyperthyroid patients a positive correlation was found between
QTc and plasma free T3. The authors conclude that hyperthyroidism and acute
hypothyroidism are risk factors for ventricular arrhythmias. Biondi et al., Naples
and Catanzaro, Italy, assessed cardiac performance by complete Doppler-
echocardiography and 24 hours Holter-tape registration in 23 patients with
subclinical hyperthyroidism (SH) and compared results with a control group of 30
normal subjects (C). They found an increased heart rate (82 ± 6 vs 71 ± 8 beats per
minute, p < 0.01) in SH vs C. No significant differences were observed in
supraventrical or ventrical arrhythmias. However, a significant increase in left
ventricular mass due to an increase of septal and posterior wall thickness was
present in SH. Fractional shortening and circumferential fiber shortening was
increased in SH. The authors conclude that the results support prompt treatment of
SH. (Comment: Although this report shows an effect of SH on cardiac tissue and
function, it is still not known if these changes are of pathologic significance.
The finding that there are no increased arrhythmias in SH is in agreement with the
report of Van de Wetering et al., Thyroid International, 5, 1999. I agree that
treatment for SH is certainly an option, as I can not imagine that an increased
basal heart rate would not have some consequences on the long run).
|
|